Feedback
Settings

Settings

Goto Application

1. WO2022006186 - PHENALKYLAMINES AND METHODS OF TREATING MOOD DISORDERS

Submit observation
PermaLink
Publication Number WO/2022/006186
Publication Date 06.01.2022
International Application No. PCT/US2021/039724
International Filing Date 29.06.2021
IPC
C07C 217/60 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
217Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
54having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
56with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
60linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
A61K 31/138 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
135having aromatic rings, e.g. methadone
138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61P 25/22 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
22Anxiolytics
A61P 25/24 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
24Antidepressants
CPC
A61P 25/22
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
22Anxiolytics
A61P 25/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
24Antidepressants
C07C 217/60
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
CACYCLIC OR CARBOCYCLIC COMPOUNDS
217Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
54having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
56with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
60linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Applicants
  • GILGAMESH PHARMACEUTICALS, INC. [US]/[US]
Inventors
  • KRUEGEL, Andrew Carry
Agents
  • HALEY, Christopher Keating
  • KAVANAUGH, Theresa
  • NEWMAN, Zachary R.
  • ASHRAF, Shovon
  • CAI, Yingying
  • CHOI, Boyeon
  • DAVENPORT, Andrew M.
  • DENHART, Derek
  • DUTTA, Sanjeet K.
  • GUCKAYA, Gozde
  • GUSTAFSON, Megan A.
  • GUTIERREZ, Gregory Daniel
  • HURT, Nicholas S.
  • STONE, Samuel S.
  • UITTO, Olivia D.
  • WADEKAR, Suhrid
  • XU, Lily
  • ZHANG, Clark
Priority Data
63/045,45829.06.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PHENALKYLAMINES AND METHODS OF TREATING MOOD DISORDERS
(FR) PHÉNALKYLAMINES ET PROCÉDÉS DE TRAITEMENT DE TROUBLES DE L'HUMEUR
Abstract
(EN) Phenalkylamines and methods of treating mood disorders with phenalkylamines. Also provided are pharmaceutical compositions that include phenalkylamines.
(FR) L'invention concerne des phénalkylamines et des procédés de traitement de troubles de l'humeur par des phénalkylamines. L'invention concerne également des compositions pharmaceutiques qui comprennent des phénalkylamines.
Latest bibliographic data on file with the International Bureau
# -